United Services Automobile Association lessened its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 8.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,810 shares of the company’s stock after selling 859 shares during the period. United Services Automobile Association’s holdings in USANA Health Sciences were worth $779,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC acquired a new stake in USANA Health Sciences during the 2nd quarter valued at approximately $27,000. LS Investment Advisors LLC acquired a new stake in USANA Health Sciences during the 2nd quarter valued at approximately $32,000. Advisory Services Network LLC acquired a new stake in USANA Health Sciences during the 2nd quarter valued at approximately $65,000. NEXT Financial Group Inc acquired a new stake in USANA Health Sciences during the 2nd quarter valued at approximately $79,000. Finally, Meeder Asset Management Inc. lifted its stake in USANA Health Sciences by 737.6% during the 2nd quarter. Meeder Asset Management Inc. now owns 1,558 shares of the company’s stock valued at $123,000 after acquiring an additional 1,372 shares during the period. 63.40% of the stock is currently owned by institutional investors.
USNA opened at $68.40 on Friday. The firm has a fifty day moving average price of $68.75 and a 200 day moving average price of $73.13. USANA Health Sciences, Inc. has a 1 year low of $58.30 and a 1 year high of $125.61. The stock has a market cap of $1.50 billion, a P/E ratio of 15.03 and a beta of 0.39.
USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, July 23rd. The company reported $0.91 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.93 by ($0.02). USANA Health Sciences had a net margin of 9.68% and a return on equity of 27.22%. The firm had revenue of $256.00 million during the quarter, compared to analyst estimates of $254.66 million. During the same quarter in the prior year, the firm earned $1.36 earnings per share. The business’s revenue for the quarter was down 15.1% on a year-over-year basis. Analysts forecast that USANA Health Sciences, Inc. will post 3.78 earnings per share for the current fiscal year.
USNA has been the subject of several research reports. TheStreet cut shares of USANA Health Sciences from a “b-” rating to a “c+” rating in a research note on Thursday, July 11th. Pivotal Research reiterated a “buy” rating on shares of USANA Health Sciences in a research note on Wednesday, July 24th. ValuEngine upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Jefferies Financial Group initiated coverage on shares of USANA Health Sciences in a research note on Thursday, August 22nd. They issued a “hold” rating and a $65.00 target price for the company. Finally, Sidoti cut shares of USANA Health Sciences from a “buy” rating to a “neutral” rating and set a $70.00 target price for the company. in a research note on Wednesday, July 3rd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. USANA Health Sciences currently has a consensus rating of “Hold” and an average price target of $70.00.
In related news, Director Robert Auciaux sold 4,018 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $71.87, for a total value of $288,773.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 42.50% of the company’s stock.
USANA Health Sciences Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Recommended Story: Initial Coin Offering (ICO)
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.